UBS has maintained its price target for Safran at €200, citing that the company's 2025 and 2028 objectives are more conservative than anticipated. The analyst notes that while investors expected some conservatism, the targets still fall below expectations. Safran projects a 10% sales growth in 2025, with operating income between €4.7 and €4.8 billion, and free cash flow of €2.8 to €3 billion. For the 2024-2028 period, the group anticipates annual sales growth of 7-9%, operating income of €6 to €6.5 billion by 2028, and cumulative free cash flow of €15 to €17 billion.